Humacyl (Humacyte Inc.) is a bioengineered human acellular vessel proposed for use as a conduit for hemodialysis in patients with end stage renal disease.
Humacyl (Humacyte Inc.) is a bioengineered human acellular vessel proposed for use as a conduit for hemodialysis in patients with end stage renal disease.